Dr. Anne Fagan
- 431 Publications
For more than a decade, Dr. Anne Fagan has been conducting research into identifying biomarkers that develop prior to symptoms of Alzheimer’s disease.
Dr. Fagan is a Research Professor in the Department of Neurology, Knight Alzheimer’s Disease Research Center (KADRC) Investigator and Professor of Neurology at the Hope Center for Neurological Disorders within the Washington University School of Medicine in St. Louis, Missouri. She is currently involved in a study that seeks to understand the long-term impacts of biomarker changes in people aged 45 to 74 years old whose parents suffered from Alzheimer’s, and who are thus more susceptible to developing the disease themselves.
“By the time symptoms bring people into the clinic, their brains are already atrophied. It is highly unlikely that any sort of intervention is going to bring back neurons that have died. But if we can identify people with underlying pathology while their thinking skills are still intact, we can put them in clinical trials to try to stop, or maybe even reverse, the disease process.”
-Dr. Anne Fagan